Next Article in Journal
Advances in HPV Vaccination in People Living with HIV: A Review
Previous Article in Journal
Carrier-Protein-Free Pneumococcal Glycoconjugate Vaccines Enabled by SPAAC: Serotype 15C CPS–PADRE Conjugates and the Impact of an RR Cleavage Motif
Previous Article in Special Issue
A Pool of Ferritin Nanoparticles Delivering Six Proteins of African Swine Fever Virus Induces Robust Humoral and Cellular Immune Responses in Pigs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Oral Bait Immunization of Eurasian Wild Boar (Sus scrofa) Against African Swine Fever with “ASFV-G-ΔI177L”: Bait Performance, Immunogenicity, and Environmental Monitoring

1
Nuremberg Zoo, 90480 Nuremberg, Germany
2
IUCN SSC Wild Pig Specialist Group, 50735 Cologne, Germany
3
Tapir and Suiform Taxon Advisory Group of the European Association of Zoos and Aquaria, 1018 DC Amsterdam, The Netherlands
4
Friedrich Loeffler Institut, 17493 Greifswald, Germany
5
Zoetis Manufacturing and Research, 17813 L’Hostalnou de Bianya (Olot), Spain
6
SaBio, Instituto de Investigación en Recursos Cinegéticos (IREC, CSIC & UCLM), 13005 Ciudad Real, Spain
7
Ceva Tiergesundheit GmbH, 14469 Potsdam, Germany
8
Ceva Tiergesundheit GmbH, 33500 Libourne, France
*
Author to whom correspondence should be addressed.
Vaccines 2026, 14(2), 193; https://doi.org/10.3390/vaccines14020193
Submission received: 22 January 2026 / Revised: 17 February 2026 / Accepted: 18 February 2026 / Published: 21 February 2026

Abstract

Background/Objectives: African swine fever is currently the most devastating viral disease affecting domestic and wild suids, causing major economic losses and severe impacts on natural populations. Oral immunization could become an important tool to control the panzootic and support wild pig conservation. However, this requires safe and effective vaccines, baits accepted by target species, and vaccine reservoirs that reliably release the vaccine during bait intake while maintaining vaccine integrity. Methods: We evaluated different bait types and vaccine containers in four wild Suiformes species, including Eurasian wild boar. In the same wild boar, we assessed oral vaccination with the live attenuated vaccine candidate “ASFV-G-ΔI177L”. Environmental monitoring approaches were applied to detect potential virus shedding, and vaccine immunogenicity and dissemination were evaluated. Vaccine stability was tested in vitro in two container types under different temperature conditions. Results: Bait uptake and container performance varied between manufacturers and among species. Environmental samples were largely negative for vaccine virus genome under controlled laboratory conditions, with only a few positive cotton ropes (0.43% of all samples). After oral bait vaccination, 45% (9/20) of wild boar seroconverted, with a higher proportion in animals receiving the vaccine in the slightly less attractive bait (gelatine-based). Vaccine virus dissemination was limited to a small number of organs, including gastrohepatic and mandibular lymph nodes. Conclusions: Our findings demonstrate that wild pigs can be vaccinated orally with “ASFV-G-ΔI177L” while virus shedding appears minimal. Although the tested baits show potential for multiple target species, baits and containers require optimization. Environmental monitoring methods also need refinement for field application.
Keywords: African swine fever virus; environmental DNA detection; immunogenicity; non-invasive sampling; oral vaccination; Suiformes; wild boar; conservation African swine fever virus; environmental DNA detection; immunogenicity; non-invasive sampling; oral vaccination; Suiformes; wild boar; conservation

Share and Cite

MDPI and ACS Style

Beckmann, J.; Blome, S.; Bujan, N.; Gortázar, C.; Holzum, T.; Ortmann, S.; Relimpio, D.; Schäfer, A.; Viaplana, E.; Vos, A.; et al. Oral Bait Immunization of Eurasian Wild Boar (Sus scrofa) Against African Swine Fever with “ASFV-G-ΔI177L”: Bait Performance, Immunogenicity, and Environmental Monitoring. Vaccines 2026, 14, 193. https://doi.org/10.3390/vaccines14020193

AMA Style

Beckmann J, Blome S, Bujan N, Gortázar C, Holzum T, Ortmann S, Relimpio D, Schäfer A, Viaplana E, Vos A, et al. Oral Bait Immunization of Eurasian Wild Boar (Sus scrofa) Against African Swine Fever with “ASFV-G-ΔI177L”: Bait Performance, Immunogenicity, and Environmental Monitoring. Vaccines. 2026; 14(2):193. https://doi.org/10.3390/vaccines14020193

Chicago/Turabian Style

Beckmann, Jörg, Sandra Blome, Nuria Bujan, Christian Gortázar, Theresa Holzum, Steffen Ortmann, David Relimpio, Alexander Schäfer, Elisenda Viaplana, Ad Vos, and et al. 2026. "Oral Bait Immunization of Eurasian Wild Boar (Sus scrofa) Against African Swine Fever with “ASFV-G-ΔI177L”: Bait Performance, Immunogenicity, and Environmental Monitoring" Vaccines 14, no. 2: 193. https://doi.org/10.3390/vaccines14020193

APA Style

Beckmann, J., Blome, S., Bujan, N., Gortázar, C., Holzum, T., Ortmann, S., Relimpio, D., Schäfer, A., Viaplana, E., Vos, A., & Friedrichs, V. (2026). Oral Bait Immunization of Eurasian Wild Boar (Sus scrofa) Against African Swine Fever with “ASFV-G-ΔI177L”: Bait Performance, Immunogenicity, and Environmental Monitoring. Vaccines, 14(2), 193. https://doi.org/10.3390/vaccines14020193

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop